This site is intended for healthcare professionals
Lung cancer_766060478_pink.jpg

Lung Cancer Nexus

Last updated: 29th May 2026
Published: 29th May 2026
Lung Cancer Nexus

The Medthority Lung Cancer Nexus brings together the latest news and resources for healthcare professionals working in non–small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). From congress coverage to interviews and insights from clinical experts, the Lung Cancer Nexus combines the latest data and treatment advances with practical guidance for everyday clinical practice to support clinical decision-making.

Latest resources

ASCO 2026
News
Seven-year benefit with lorlatinib
Read more
Image at a conference
Overview
WCLC 2025 highlights
Read more
Congress highlights
Data at a glance
Read more
Congress highlights
Shifting the NSCLC landscape
Read more
Congress highlights
Targeted therapies
Read more

News

Blue test tubes arranged in a line, disappearing into the background
Drug news
Patritumab BLA withdrawn by Merck
Read more
Blue test tubes arranged in a line, disappearing into the background
Drug news
NICE recommends Tagrisso Combo
Read more
Blue test tubes arranged in a line, disappearing into the background
Drug news
Opdivo regimen approved in EU
Read more
Blue test tubes arranged in a line, disappearing into the background
Drug news
Emrelis wins FDA nod in NSCLC
Read more
Blue test tubes arranged in a line, disappearing into the background
Drug news
FDA approves Roche CDx for Emrelis
Read more
Blue test tubes arranged in a line, disappearing into the background
Drug news
iTeos, GSK end belrestotug program
Read more
Blue test tubes arranged in a line, disappearing into the background
Drug news
Roche AI diagnostic approved
Read more
Blue test tubes arranged in a line, disappearing into the background
Drug news
NICE Terminates Appraisal for Tevimbra in NSCLC
Read more
Blue test tubes arranged in a line, disappearing into the background
Drug news
Ivonescimab Shows Strong Results in NSCLC
Read more
Blue test tubes arranged in a line, disappearing into the background
Drug news
Tarlatamab Shows Survival Benefit
Read more
Blue test tubes arranged in a line, disappearing into the background
Drug news
Imfinzi Regimen Approved in EU
Read more
Blue test tubes arranged in a line, disappearing into the background
Drug news
Tevimbra Approved for Lung Cancer
Read more
Blue test tubes arranged in a line, disappearing into the background
Drug news
Tagrisso Reinforced as EGFR Lung Cancer Therapy
Read more
Blue test tubes arranged in a line, disappearing into the background
Drug news
EU Approves Imfinzi for Lung Cancer
Read more
Blue test tubes arranged in a line, disappearing into the background
Drug news
NICE Terminates Tecentriq Appraisal
Read more

Congress highlights

Stay ahead of the latest advances in lung cancer care with curated updates from the world’s leading oncology congresses.

TAKE A LOOK

Related guidelines

Guidelines
Guideline
Management of patients with early-stage non-small cell lung cancer: an American College of Chest Physicians clinical practice guideline
Read more
Guidelines
Guideline
The STS clinical practice guideline on surgical management of oligometastatic NSCLC
Read more
Guidelines
Guideline
Screening for lung cancer: 2023 guideline update from the American Cancer Society
Read more
Guidelines
Guideline
Adjuvant systemic therapy and adjuvant radiation therapy for stage I to IIIA completely resected non–small-cell lung cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update
Read more
Guidelines
Guideline
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Guidelines
Read more
Guidelines
Guideline
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Read more
Guidelines
Guideline
Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines
Read more

Complete the form below to receive our regular round-up of the latest clinical news and medical education resources on Medthority, straight to your inbox.

* = required information 

 

By providing your email address, you are opting in to receive our monthly newsletter.

By submitting this form you agree to our Terms of Use and Privacy Policy. You can withdraw your consent at any time by clicking the ‘unsubscribe’ link found at the bottom of every email.

Welcome:
Register
Updates in your area
of interest
Articles your peers
are looking at
Bookmarks
saved
Days to your
next event